Healthcare & Life Sciences
Proviva Therapeutics
China
series-a
series-a
Stage
1
Investors
About
Proviva Therapeutics is a clinical-stage biotechnology company developing pro-cytokine fusion protein therapeutics to treat cancer and infectious diseases.
Explore Proviva Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.